Vimarsana
Biggest News Aggregation in the World

Her2 Status News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Her2 Status. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Her2 Status Today - Breaking & Trending Today

Biomarker Data and Patient Preference Inform Perioperative Therapy Selection in Early HER2+ Breast Cancer - Vimarsana News

Biomarker Data and Patient Preference Inform Perioperative Therapy Selection in Early HER2+ Breast Cancer

Published: December 13, 2023

Maria Hafez, MD, discusses factors such as HER2 status, lymph node negativity, and risk stratification that influence the selection of adjuvant treatment approaches for patients with early-stage HER2-positive breast cancer and expands on pivotal data that have changed the paradigm.

Source: onclive.com
Related Topics:
United StatesMaria HafezSidney Kimmel Medical CollegeScience SummitBreast Cancer Clinical ResearchSidney Kimmel Cancer CenterThomas Jefferson UniversityBiomarker DataPerioperative TherapyHer2 Breast CancerBreast CancerMaria Hafez MdOnclive State Of The Science SummitHer2 Status
Optimal Workup Strategies in Advanced Endometrial Cancer - Vimarsana News

Optimal Workup Strategies in Advanced Endometrial Cancer

Published: October 30, 2023

Explore the case of a 67-year-old patient with recurrent endometrial cancer, highlighting the importance of MMR testing, NGS, and emerging treatment options in today's landscape.

Source: onclive.com
Related Topics:
Optimizing TherapyEndometrial CancerRecent Data HighlightsWorkup StrategiesAdvanced EndometrialTreatment ApproachRecurrent CancerCheckpoint InhibitorMmr TestingLynch SyndromePole TestingHer2 StatusEr Pr StatusEmerging TherapiesGynecologic CancerGenetic ReferralsOvarian ConservationAdvanced Endometrial CancerTreatment ParadigmStaging Paradigm